These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 9462602)
1. Safety and efficacy of closed-loop arbutamine stress echocardiography for detection of coronary artery disease. International Arbutamine Study Group. Bach DS; Cohen JL; Fioretti PM; Ginzton LE; Sklar J; Zabalgoitia M; Crouse L Am J Cardiol; 1998 Jan; 81(1):32-5. PubMed ID: 9462602 [TBL] [Abstract][Full Text] [Related]
2. Arbutamine stress thallium-201 single-photon emission computed tomography using a computerized closed-loop delivery system. Multicenter trial for evaluation of safety and diagnostic accuracy. The International Arbutamine Study Group. Kiat H; Iskandrian AS; Villegas BJ; Starling MR; Berman DS J Am Coll Cardiol; 1995 Nov; 26(5):1159-67. PubMed ID: 7594027 [TBL] [Abstract][Full Text] [Related]
3. Comparison of arbutamine and exercise echocardiography in diagnosing myocardial ischemia. Cohen A; Weber H; Chauvel C; Monin JL; Dib JC; Diebold B; Guéret P Am J Cardiol; 1997 Mar; 79(6):713-6. PubMed ID: 9070546 [TBL] [Abstract][Full Text] [Related]
4. Arbutamine vs. exercise stress testing in patients with coronary artery disease: evaluation by echocardiography and electrocardiography. Ginzton LE; Pool PE; Appleton C; Mohiuddin S; Robertson WS; Ismail GD; Bach DS; Armstrong WF Int J Cardiol; 1996 Nov; 57(1):81-9. PubMed ID: 8960948 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of computerized closed-loop delivery of arbutamine: a new pharmacologic myocardial stress modality for the assessment of coronary artery disease. The European Arbutamine Study Group. Cramer MJ; Jaarsma W; Sutherland GR; Nihoyannopoulos P; Fioretti P; Tan LB; Schröder K; Visser CA J Am Soc Echocardiogr; 1995; 8(6):854-63. PubMed ID: 8611285 [TBL] [Abstract][Full Text] [Related]
6. Arbutamine echocardiography: efficacy and safety of a new pharmacologic stress agent to induce myocardial ischemia and detect coronary artery disease. The International Arbutamine Study Group. Cohen JL; Chan KL; Jaarsma W; Bach DS; Muller DW; Starling MR; Armstrong WF J Am Coll Cardiol; 1995 Nov; 26(5):1168-75. PubMed ID: 7594028 [TBL] [Abstract][Full Text] [Related]
7. Stress testing with closed-loop arbutamine as an alternative to exercise. The International Arbutamine Study Group. Dennis CA; Pool PE; Perrins EJ; Mohiuddin SM; Sklar J; Kostuk WJ; Muller DW; Starling MR J Am Coll Cardiol; 1995 Nov; 26(5):1151-8. PubMed ID: 7594026 [TBL] [Abstract][Full Text] [Related]
8. Direct comparison of arbutamine and dobutamine stress testing with myocardial perfusion imaging and echocardiography in patients with coronary artery disease. Shehata AR; Ahlberg AW; Gillam LD; Mascitelli VA; Piriz JM; Fleming RA; Chen C; Waters DD; Heller GV Am J Cardiol; 1997 Sep; 80(6):716-20. PubMed ID: 9315575 [TBL] [Abstract][Full Text] [Related]
9. Adequacy of low-stress arbutamine to provoke myocardial ischemia during echocardiography. International Arbutamine Study Group. Bach DS; Armstrong WF Am J Cardiol; 1995 Aug; 76(4):259-62. PubMed ID: 7618620 [TBL] [Abstract][Full Text] [Related]
10. Effect of atenolol or metoprolol on arbutamine stress echocardiography in patients suspected of having coronary artery disease. Weissman NJ; Sheris SJ; Picard MH; Bach DS; Sklar J; Cohen JL Am J Cardiol; 1998 Sep; 82(6):830-2, A10. PubMed ID: 9761104 [TBL] [Abstract][Full Text] [Related]